Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2020

1
Category Pharmaceuticals Healthcare

• Glioblastoma Multiforme Therapeutics in Major
  Developed Markets to 2020 - Growth to Hinge on
  the Success of Personalized Vaccine Following
  Early Approval in Germany

2
Synopsis

• GBI Research, a leading business intelligence
  provider, has released its latest research
  report, "Glioblastoma Multiforme Therapeutics in
  Major Developed Markets to 2020 - Growth to Hinge
  on the Success of Personalized Vaccine Following
  Early Approval in Germany".
• Browse complete Report http//www.aarkstore.co
  m/pharmaceuticals-healthcare/94560/glioblastoma-mu
  ltiforme-therapeutics-in-major-developed-markets-t
  o-2020-growth-to-hinge-on-the-success-of-personali
  zed-vaccine-following-early-approval-in-germany

3
Summary

• Due to the poor prognosis under currently
  available treatments, therapies with high potency
  are in strong demand in the Glioblastoma
  Multiforme (GBM) market. In newly diagnosed
  patients, the current standard of care,
  comprising resection surgery, radiation therapy
  and chemotherapy with Mercks Temodar
  (temozolomide), has a maximum Overall Survival
  (OS) of 15 months and almost inevitable tumor
  recurrence. Current therapeutic options for
  recurrent GBM are Roches Avastin (bevacizumab),
  carmustine and other chemotherapy drugs used
  off-label. However, they only offer limited OS
  benefit, leaving high unmet need in this patient
  segment.

4
Table of contents

• 1 Table of Contents 41.1 List of Tables 61.2
  List of Figures 72 Introduction 82.1 Disease
  Introduction 82.2 Classification of Brain Tumors
  92.3 Tumor Grading 112.4 Subtypes of
  Glioblastoma Multiforme 122.5 Etiology 122.6
  Pathophysiology 13

5
Related Reports

• http//www.aarkstore.com/pharmaceuticals-healthcar
  e/110859/mens-health-changing-male-attitudes-to-he
  alth-to-improve-prognosis-and-outcomes
• http//www.aarkstore.com/pharmaceuticals-healthcar
  e/110732/almac-discovery-ltd-product-pipeline-revi
  ew-2015
• http//www.aarkstore.com/pharmaceuticals-healthcar
  e/110731/summit-corporation-plc-product-pipeline-r
  eview-2015
• http//www.aarkstore.com/pharmaceuticals-healthcar
  e/110730/valentia-biopharma-sl-product-pipeline-re
  view-2015
• http//www.aarkstore.com/pharmaceuticals-healthcar
  e/110729/immunomic-therapeutics-inc-product-pipeli
  ne-review-2015

6
Glioblastoma Multiforme Therapeutics in Major
Developed Markets to 2020 - Growth to Hinge on
the Success of Personalized Vaccine Following
Early Approval in Germany

• Published
  June 2014 112 Pages
• Glioblastoma Multiforme Therapeutics in Major
  Developed Markets to 2020 - Growth to Hinge on
  the Success of Personalized Vaccine Following
  Early Approval in Germany
• Price

Format Price
PDF 4995

7
Contact Us
Office Office No. - 809, 8th Floor,B-Wing,
Mahaavir Icon, Plot No.- 89 90,
Sector-15,CBD-Belapur, Navi Mumbai
400614, Maharashtra, India. Telefax No 91 22
4127 6660 24/7 Online Support 91
9987295242 General Inquiries 91 - 22 2756
4953
You Can Visit http//www.aarkstore.com OR Mail
us at contact_at_aarkstore.com Blog
http//www.aarkstore.com/blog/ Conference
http//conference.aarkstore.com/ News
http//www.aarkstore.com/news